Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued-Reference-Cited by-同舟云学术

Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued

Published:1992-10 Issue:4 Volume:43 Page:357-363
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Przuntek H.,Welzel D.,Blümner E.,Danielczyk W.,Letzel H.,Kaiser H. -J.,Kraus P. H.,Riederer P.,Schwarzmann D.,Wolf H.,Überla K.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02220609.pdf

Reference37 articles.

1. Hoehn HM (1983) Parkinsonism treated with levodopa, progression and mortality. J Neurol Transm 19 [Suppl]: 253–264

2. Guillard A, Chastany C, Fenelon G (1986) Etude à long terme de 416 cas de maladie de parkinson. Facteurs de pronostic et implications thérapeutiques. Rev Neurol (Paris) 142: 207–214

3. Muenter MD, Tyce GM (1971) L-Dopa therapy of parkinson disease plasma L-Dopa concentration therapeutic response and side effects. Mayo Clin Pro 46: 231–239

4. Fischer PA, Schneider E, Jacobi P et al. (1973) Langzeitstudie zur Effektivität der L-Dopa-Therapie bei Parkinson-Kranken. Nervenarzt 44: 128–135

5. Baas H, Fischer PA (1986) Fluktuationen der Beweglichkeit beim Parkinson-Syndrom. In: Fischer PA (ed) Spätsyndrome der Parkinson-Krankheit. Roche, Basel, pp 213–234

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A study of prevention and regression of cardiac hypertrophy with a prolactin inhibitor in a biological model of ventricular hypertrophy caused by aorto caval fistulae in rat;Cardiovascular Pathology;2013-09

2. Divergent Effects of Various Diabetes Drugs on Cardiovascular Prognosis;Reviews in Cardiovascular Medicine;2013-06-30

3. The Role of Oxidative Stress in Parkinson's Disease;Journal of Parkinson's Disease;2013

4. Why does quick-release bromocriptine decrease cardiac events?;Diabetes, Obesity and Metabolism;2011-09-06

5. CATECHOL O-METHYLTRANSFERASE ENZYME COFACTOR S-ADENOSYL L METHIONINE AND RELATED MECHANISMS;INT REV NEUROBIOL;2010